BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 15713663)

  • 1. Cyclin D1 inhibits peroxisome proliferator-activated receptor gamma-mediated adipogenesis through histone deacetylase recruitment.
    Fu M; Rao M; Bouras T; Wang C; Wu K; Zhang X; Li Z; Yao TP; Pestell RG
    J Biol Chem; 2005 Apr; 280(17):16934-41. PubMed ID: 15713663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter.
    Zuo Y; Qiang L; Farmer SR
    J Biol Chem; 2006 Mar; 281(12):7960-7. PubMed ID: 16431920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor suppressor SMAR1 mediates cyclin D1 repression by recruitment of the SIN3/histone deacetylase 1 complex.
    Rampalli S; Pavithra L; Bhatt A; Kundu TK; Chattopadhyay S
    Mol Cell Biol; 2005 Oct; 25(19):8415-29. PubMed ID: 16166625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tudor-SN, a novel coactivator of peroxisome proliferator-activated receptor γ protein, is essential for adipogenesis.
    Duan Z; Zhao X; Fu X; Su C; Xin L; Saarikettu J; Yang X; Yao Z; Silvennoinen O; Wei M; Yang J
    J Biol Chem; 2014 Mar; 289(12):8364-74. PubMed ID: 24523408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes.
    Bonofiglio D; Santoro A; Martello E; Vizza D; Rovito D; Cappello AR; Barone I; Giordano C; Panza S; Catalano S; Iacobazzi V; Dolce V; Andò S
    Biochim Biophys Acta; 2013 Jun; 1831(6):1027-36. PubMed ID: 23370576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional and physical interaction between the histone methyl transferase Suv39H1 and histone deacetylases.
    Vaute O; Nicolas E; Vandel L; Trouche D
    Nucleic Acids Res; 2002 Jan; 30(2):475-81. PubMed ID: 11788710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation.
    Fajas L; Egler V; Reiter R; Hansen J; Kristiansen K; Debril MB; Miard S; Auwerx J
    Dev Cell; 2002 Dec; 3(6):903-10. PubMed ID: 12479814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma.
    Sarruf DA; Iankova I; Abella A; Assou S; Miard S; Fajas L
    Mol Cell Biol; 2005 Nov; 25(22):9985-95. PubMed ID: 16260612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclin D1 represses p300 transactivation through a cyclin-dependent kinase-independent mechanism.
    Fu M; Wang C; Rao M; Wu X; Bouras T; Zhang X; Li Z; Jiao X; Yang J; Li A; Perkins ND; Thimmapaya B; Kung AL; Munoz A; Giordano A; Lisanti MP; Pestell RG
    J Biol Chem; 2005 Aug; 280(33):29728-42. PubMed ID: 15951563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipocyte expression of the glucose-dependent insulinotropic polypeptide receptor involves gene regulation by PPARγ and histone acetylation.
    Kim SJ; Nian C; McIntosh CH
    J Lipid Res; 2011 Apr; 52(4):759-70. PubMed ID: 21245029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small heterodimer partner-interacting leucine zipper protein inhibits adipogenesis by regulating peroxisome proliferator-activated receptor γ activity.
    Jang H; Kim HJ; Kim DH; Park JK; Sun WS; Hwang S; Oh KB; Jang WG; Lee JW
    Life Sci; 2015 Jul; 132():49-54. PubMed ID: 25896661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of HDAC3 promotes ligand-independent PPARγ activation by protein acetylation.
    Jiang X; Ye X; Guo W; Lu H; Gao Z
    J Mol Endocrinol; 2014 Oct; 53(2):191-200. PubMed ID: 24982244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. INSM1 functions as a transcriptional repressor of the neuroD/beta2 gene through the recruitment of cyclin D1 and histone deacetylases.
    Liu WD; Wang HW; Muguira M; Breslin MB; Lan MS
    Biochem J; 2006 Jul; 397(1):169-77. PubMed ID: 16569215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclin G2 regulates adipogenesis through PPAR gamma coactivation.
    Aguilar V; Annicotte JS; Escote X; Vendrell J; Langin D; Fajas L
    Endocrinology; 2010 Nov; 151(11):5247-54. PubMed ID: 20844002
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-phosphoinositide-dependent protein kinase-1 activates the peroxisome proliferator-activated receptor-gamma and promotes adipocyte differentiation.
    Yin Y; Yuan H; Wang C; Pattabiraman N; Rao M; Pestell RG; Glazer RI
    Mol Endocrinol; 2006 Feb; 20(2):268-78. PubMed ID: 16150867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone deacetylase inhibitors suppress the induction of c-Jun and its target genes including COX-2.
    Yamaguchi K; Lantowski A; Dannenberg AJ; Subbaramaiah K
    J Biol Chem; 2005 Sep; 280(38):32569-77. PubMed ID: 15994313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ATF3 represses PPARγ expression and inhibits adipocyte differentiation.
    Jang MK; Jung MH
    Biochem Biophys Res Commun; 2014 Nov; 454(1):58-64. PubMed ID: 25445599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic regulation of vascular smooth muscle cell proliferation and neointima formation by histone deacetylase inhibition.
    Findeisen HM; Gizard F; Zhao Y; Qing H; Heywood EB; Jones KL; Cohn D; Bruemmer D
    Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):851-60. PubMed ID: 21233448
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Silencing of transcription of the human luteinizing hormone receptor gene by histone deacetylase-mSin3A complex.
    Zhang Y; Dufau ML
    J Biol Chem; 2002 Sep; 277(36):33431-8. PubMed ID: 12091390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-thiazolidinedione partial peroxisome proliferator-activated receptor gamma ligand inhibits vascular smooth muscle cell growth.
    Bruemmer D; Berger JP; Liu J; Kintscher U; Wakino S; Fleck E; Moller DE; Law RE
    Eur J Pharmacol; 2003 Apr; 466(3):225-34. PubMed ID: 12694805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.